Key result
Clinical phenotypes affect ~94% of advanced heart failure patients, led by frailty and frequent overlap.
Cohort (n=936)
No
This study validates the comprehensiveness of the newly proposed NHLBI clinical phenotypes for advanced heart failure in a real-world community cohort, highlighting the high prevalence of frailty and cumulative phenotypic burden.
Answers are grounded in this paper and cite their sources.
May inform prognosis discussions in advanced HF; leaves open whether phenotype-guided therapy improves outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Steiger et al. (2026) conducted a cohort in Advanced Heart Failure (n=936). Advanced heart failure clinical phenotypes was evaluated on Prevalence and overlap of clinical AHF phenotypes (cardiorenal, hepatic dysfunction, right HF, low output, and frailty) and adverse social determinants of health.. In a community cohort of adults with advanced heart failure, 94% were categorized into at least one clinical phenotype, with frailty being the most prevalent (two-thirds) and phenotypic overlap occurring frequently.
Synapse has enriched 10 related papers. Consider them for comparative context: